ELVN — Enliven Therapeutics Inc. price, chart and key statistics

Price data

Price

$41.25

YTD price return

+167.86%

YTD total return

+167.86%

Next earnings

Nov 11, 2026

Market cap

3B2020-03 277M2026-10 3B+991.1% over the window

Enterprise value

2.1B

Shares outstanding

73.3M2019-12 702.5K2026-06 73.3M+10329.9% over the window

52W low

$14.79

52W high

$62.32

From 52W high

-33.81%

From 52W low

+179.00%

52W range

56%

Volume

Rel volume

1.31×

30D volume

1.5M

30D $ vol

67.9M

Fundamentals

EPS (ttm)

-$1.672021-06 -$2.672026-06 -$1.67-37.4% over the window

FCF (ttm)

-67M2019-12 -22M2026-06 -67M+204.5% over the window

FCF/share

-$0.912019-12 -$31.342026-06 -$0.91-97.1% over the window

Book value/share

$12.222019-12 -$69.532026-06 $12.22-117.6% over the window

ROE

-11.83%2020-12 -49.0%2026-06 -11.8%-75.8% over the window

ROA

-11.64%2019-12 -70.5%2026-06 -11.6%-83.5% over the window

Current ratio

64.072019-12 7.292026-06 64.07+778.3% over the window

Growth (CAGR, ttm) · 10Y

Shares

+23.71%2025-06-30 → 2026-06-3059.2M → 73.3M (+23.7% total)+21.20%2023-06-30 → 2026-06-3041.2M → 73.3M (+78.1% total)+22.80%2021-06-30 → 2026-06-3026.2M → 73.3M (+179.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+48.19%2025-06-30 → 2026-06-30$8.25 → $12.22 (+48.2% total)+21.68%2023-06-30 → 2026-06-30$6.78 → $12.22 (+80.2% total)+37.62%2021-06-30 → 2026-06-30$2.48 → $12.22 (+393.6% total)n/a

Price

+86.56%2025-10-20 → 2026-10-20$22.12 → $41.25 (+86.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+48.28%2023-10-20 → 2026-10-20$12.65 → $41.25 (+226.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+62.60%2021-10-20 → 2026-10-20$3.63 → $41.25 (+1036.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+86.56%2025-10-20 → 2026-10-20$22.12 → $41.25 (+86.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+48.28%2023-10-20 → 2026-10-20$12.65 → $41.25 (+226.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+62.60%2021-10-20 → 2026-10-20$3.63 → $41.25 (+1036.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-24.7×2020-03 -11.812026-10 -28.53+141.7% over the window

Fwd P/E

-15.9×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.4×2020-03 2.632026-10 3.38+28.2% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-2.22%2019-12 -7.9%2026-06 -1.8%-77.3% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 73.3M ÷ 59.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-23.71%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-23.71%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-23.71%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3B). Same caveat as the cash buyback yield.

0.00%2019-12 0.0%2026-06 0.0%

Vs own 10Y history

P/B

62nd